Search Results - "Bouygues, A."

406 Aflibercept (Zaltrap) directly attenuates the migration and invasion of colorectal cancer cells by Bouygues, A, Mésange, P, Ayadi, M, Poindessous, V, Chiron, M, Dochy, E, André, T, de Gramont, A, Larsen, A.K

Get full text

Combined measurements of 17Oexcess and d-excess in African monsoon precipitation: Implications for evaluating convective parameterizations by Landais, A, Risi, C, Bony, S, Vimeux, F, Descroix, L, Falourd, S, Bouygues, A

“…Water stable isotopes ( delta 18O, ID) are useful tools to depict and to understand the atmospheric water cycle. In tropical regions, they record the…”
Get full text

Influence of HIF-2alpha deregulation and overexpression of VEGF ligands on the response to aflibercept: Identification of predictive biomarkers by Larsen, A.K., Thouroude, S., Louadj, L., Sabbah, M., Dochy, E., de Gramont, A., Denis, J.A., Bouygues, A.

Get full text

P-221 Acquired 5-FU resistance in CRC models is accompanied by upregulation of VEGF-VEGFR1 signaling, increased migration and invasion that can be attenuated by aflibercept by Bouygues, A., Mesange, P., Ayadi, M., Chiron, M., Dochy, E., Andre, T., de Gramont, A., Larsen, A.

Get full text

PD-010 Erlotinib attenuates bevacizumab-mediated activation of EGFR-survival signaling in CRC models independent of KRAS status providing a rational basis for the DREAM phase III clinical trial by Mésange, P., Bouygues, A., Muller, D., Savina, A., Chibaudel, B., Tournigand, C., André, T., de Gramont, A., Larsen, A.

Get full text

1581PMOUSE-DREAM: VEGF INHIBITION IS ACCOMPANIED BY EGFR ACTIVATION IN COLORECTAL CANCER MODELS INDEPENDENT OF KRAS STATUS PROVIDING A RATIONAL FOR COMBINATIONS OF BEVACIZUMAB AND ERLOTINIB IN THE POSITIVE GERCOR PHASE III DREAM TRIAL by Larsen, A.K., Poindessous, V., Bouygues, A., Muller, D., Savina, A., Chibaudel, B., Tournigand, C., André, T., De Gramont, A., Mesange, P.

“…Abstract Aim: We have recently shown that EGFR- and VEGF(R)- targeted small molecules showed synergistic activity in colorectal cancer (CRC) models refractory…”
Get full text

Mouse-Dream: Vegf Inhibition is Accompanied By Egfr Activation in Colorectal Cancer Models Independent of Kras Status Providing a Rational for Combinations of Bevacizumab and Erlotinib in the Positive Gercor Phase III Dream Trial by Larsen, A.K., Poindessous, V., Bouygues, A., Muller, D., Savina, A., Chibaudel, B., Tournigand, C., André, T., De Gramont, A., Mesange, P.

Get full text

Combined measurements of 0-17(excess) and d-excess in African monsoon precipitation: Implications for evaluating convective parameterizations by Landais, A., Risi, C., Bony, S., Vimeux, Françoise, Descroix, Luc, Falourd, S., Bouygues, A.

“…Water stable isotopes (δ18O, δD) are useful tools to depict and to understand the atmospheric water cycle. In tropical regions, they record the variations of…”
Get full text

Combined measurements of 17O excess and d-excess in African monsoon precipitation: Implications for evaluating convective parameterizations by Landais, A., Risi, C., Bony, S., Vimeux, F., Descroix, L., Falourd, S., Bouygues, A.

“…Water stable isotopes (δ 18O, δD) are useful tools to depict and to understand the atmospheric water cycle. In tropical regions, they record the variations of…”
Get full text

À la pêche aux plombs by Carrier, P., Legros, R., Morel, A., Le Sidaner, A., Bouygues, A., Valgueblasse, V., Gondran, G., Moesch, C., Tabouret, T., Bézanahary, H., Ly, K.H., Loustaud-Ratti, V.

Get full text

P.267 Evaluation du traitement par coagulation au plasma argon (CPA) des rectites radiques chroniques hémorragiques (RRC) au CHU de LIMOGES by Giraud, A., Le Sidaner, A., Sautereau, D., Cessot, F., Seillan, S., Legros, R., Valgueblasse, V., Bouygues, A., Cypierre, A.

“…Notre étude a pour objectif d’évaluer notre prise en charge des RRC par CPA [1, 2] et de proposer une nouvelle échelle d’évaluation des lésions endoscopiques…”
Get full text